Suppressive oligodeoxynucleotides promote the generation of regulatory T cells by inhibiting STAT1 phosphorylation

International Immunopharmacology

Volumn 23, Issue 2, 2014, Pages 516-522

  Bode, Christian ^a,b   Wang, Jing ^a   Klinman, Dennis M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Regulatory T cells; STAT transcription factors; Suppressive oligonucleotides

Indexed keywords

OLIGODEOXYNUCLEOTIDE; PEPTIDE; STAT1 PROTEIN; TRANSCRIPTION FACTOR FOXP3; OLIGODEOXYRIBONUCLEOTIDE; STAT1 PROTEIN, HUMAN; STAT1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DEGENERATION; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NORMAL HUMAN; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHORYLATION; STAT1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY;

EID: 84912533364     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.09.027     Document Type: Article

References (48)

1. M.K. Atianand, and K.A. Fitzgerald Molecular basis of DNA recognition in the immune system J Immunol 190 2013 1911
2. I. Gursel, M. Gursel, H. Yamada, K.J. Ishii, F. Takeshita, and D.M. Klinman Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation J Immunol 171 2003 1393
3. D.M. Klinman, D. Tross, S. Klaschik, H. Shirota, and T. Sato Therapeutic applications and mechanisms underlying the activity of immunosuppressive oligonucleotides AnnNYAcadSci 1175 2009 80
4. l Dong, S. Ito, K. Ishii, and D. Klinman Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong the survival of Lupus-prone NZB/W mice Arthritis Rheum 52 2004 651
5. L. Dong, S. Ito, K.J. Ishii, and D.M. Klinman Suppressive oligonucleotides protect against collagen-induced arthritis in mice Arthritis Rheum 50 2004 1686
6. C. Fujimoto, D.M. Klinman, G. Shi, H. yin, B.P. Vistica, and J.D. Lovaas A suppressive oligodeoxynucleotide inhibits ocular inflammation Clin Exp Immunol 156 2009 528
7. H. Shirota, I. Gursel, M. Gursel, and D.M. Klinman Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shock J Immunol 174 2005 4579
8. H. Shirota, M. Gursel, and D.M. Klinman Suppressive oligodeoxynucleotides inhibit Th1 differentiation by blocking IFN-gamma- and IL-12-mediated signaling J Immunol 173 2004 5002
9. S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono Regulatory T cells and immune tolerance Cell 133 2008 775
10. J.D. Fontenot, M.A. Gavin, and A.Y. Rudensky Foxp3 programs the development and function of CD4 + CD25 + regulatory T cells Nat Immunol 4 2003 330
11. M.A. Curotto de Lafaille, and J.J. Lafaille Natural and adaptive foxp3 + regulatory T cells: more of the same or a division of labor? Immunity 30 2009 626
12. S. Hori, T. Nomura, and S. Sakaguchi Control of regulatory T cell development by the transcription factor Foxp3 Science 299 2003 1057
13. R. Khattri, T. Cox, S.A. Yasayko, and F. Ramsdell An essential role for Scurfin in CD4 + CD25 + T regulatory cells Nat Immunol 4 2003 337
14. J.D. Fontenot, J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky Regulatory T cell lineage specification by the forkhead transcription factor foxp3 Immunity 22 2005 329
15. C.L. Bennett, J. Christie, F. Ramsdell, M.E. Brunkow, P.J. Ferguson, and L. Whitesell The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 Nat Genet 27 2001 20
16. W. Chen, W. Jin, N. Hardegen, K.J. Lei, L. Li, and N. Marinos Conversion of peripheral CD4 + J Exp Med 198 2003 1875
17. M.C. Fantini, C. Becker, G. Monteleone, F. Pallone, P.R. Galle, and M.F. Neurath Cutting edge: TGF-beta induces a regulatory phenotype in CD4 + J Immunol 172 2004 5149
18. K.M. Thorstenson, and A. Khoruts Generation of anergic and potentially immunoregulatory CD25 + CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen J Immunol 167 2001 188
19. D. Hackl, J. Loschko, T. Sparwasser, W. Reindl, and A.B. Krug Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs Eur J Immunol 41 2011 1334
20. M.A. Burchill, J. Yang, C. Vogtenhuber, B.R. Blazar, and M.A. Farrar IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3 + regulatory T cells J Immunol 178 2007 280
21. Z. Yao, Y. Kanno, M. Kerenyi, G. Stephens, L. Durant, and W.T. Watford Nonredundant roles for Stat5a/b in directly regulating Foxp3 Blood 109 2007 4368
22. J. Wei, O. Duramad, O.A. Perng, S.L. Reiner, Y.J. Liu, and F.X. Qin Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3 + regulatory T cells Proc Natl Acad Sci U S A 104 2007 18169
23. D. Caretto, S.D. Katzman, A.V. Villarino, E. And Gallo, and A.K. Abbas Cutting edge: the th1 response inhibits the generation of peripheral regulatory T cells J Immunol 184 2010 30
24. L.F. Lu, M.P. Boldin, A. Chaudhry, L.L. Lin, K.D. Taganov, and T. Hanada Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses Cell 142 2010 914
25. H. Ma, C. Lu, J. Ziegler, A. Liu, A. Sepulveda, and H. Okada Absence of Stat1 in donor CD4(+) T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice J Clin Invest 121 2011 2554
26. C.M. Sun, J.A. Hall, R.B. Blank, N. Bouladoux, M. Oukka, and J.R. Mora Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid J Exp Med 204 2007 1775
27. J.E. Durbin, R. Hackenmiller, M.C. Simon, and D.E. Levy Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease Cell 84 1996 443
28. X. Chen, J.J. Oppenheim, and O.M. Howard BALB/c mice have more CD4 + CD25 + T regulatory cells and show greater susceptibility to suppression of their CD4 + J Leukoc Biol 78 2005 114
29. A.M. Thornton, and E.M. Shevach Suppressor effector function of CD4 + CD25 + immunoregulatory T cells is antigen nonspecific J Immunol 164 2000 183
30. J.H. Chang, Y.J. Kim, S.H. Han, and C.Y. Kang IFN-gamma-STAT1 signal regulates the differentiation of inducible Treg: potential role for ROS-mediated apoptosis Eur J Immunol 39 2009 1241
31. J.J. Kaminski, S.A. Schattgen, T.C. Tzeng, C. Bode, D.M. Klinman, and K.A. Fitzgerald Synthetic oligodeoxynucleotides containing suppressive TTAGGG motifs inhibit AIM2 inflammasome activation J Immunol 191 2013 3876
32. F.C. Yagci, O. Aslan, M. Gursel, G. Tincer, Y. Ozdamar, and K. Karatepe Mammalian telomeric DNA suppresses endotoxin-induced uveitis J Biol Chem 285 2010 28806
33. H. Ikeuchi, T. Kinjo, and D.M. Klinman Effect of suppressive oligodeoxynucleotides on the development of inflammation-induced papillomas Cancer Prev Res (Phila) 4 2011 752
34. C. Bode, X.P. Yang, H. Kiu, and D.M. Klinman Suppressive oligodeoxynucleotides promote the development of Th17 cells PLoS One 8 2013 e67991
35. J. Zhu, and W.E. Paul Heterogeneity and plasticity of T helper cells Cell Res 20 2010 4
36. Y.K. Lee, R. Mukasa, R.D. Hatton, and C.T. Weaver Developmental plasticity of Th17 and Treg cells Curr Opin Immunol 21 2009 274
37. N. Bouladoux, J.A. Hall, J.R. Grainger, L.M. dos Santos, M.G. Kann, and V. Nagarajan Regulatory role of suppressive motifs from commensal DNA Mucosal Immunol 5 2012 623
38. Y.C. Kim, R. Bhairavabhotla, J. Yoon, A. Golding, A.M. Thornton, and D.Q. Tran Oligodeoxynucleotides stabilize Helios-expressing Foxp3 + human T regulatory cells during in vitro expansion Blood 119 2012 2810
39. D.S. Pisetsky, and C.F. Reich Inhibition of murine macrophage IL-12 production by natural and synthetic DNA Clin Immunol 96 2000 198
40. J.A. Hall, N. Bouladoux, C.M. Sun, E.A. Wohlfert, R.B. Blank, and Q. Zhu Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses Immunity 29 2008 637
41. D.F. LaRosa, A.E. Gelman, A.H. Rahman, J. Zhang, L.A. Turka, and P.T. Walsh CpG DNA inhibits CD4 + CD25 + Treg suppression through direct MyD88-dependent costimulation of effector CD4 + T cells Immunol Lett 108 2007 183
42. A. Olivier, A. Sainz-Perez, H. Dong, T. Sparwasser, L. Majlessi, and C. Leclerc The adjuvant effect of TLR agonists on CD4(+) effector T cells is under the indirect control of regulatory T cells Eur J Immunol 41 2011 2303
43. B.H. von, and C. Daniel Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer Nat Rev Drug Discov 12 2013 51
44. Q. Tang, and K. Lee Regulatory T-cell therapy for transplantation: how many cells do we need? Curr Opin Organ Transplant 17 2012 349
45. S. Nayak, O. Cao, B.E. Hoffman, M. Cooper, S. Zhou, and M.A. Atkinson Prophylactic immune tolerance induced by changing the ratio of antigen-specific effector to regulatory T cells J Thromb Haemost 7 2009 1523
46. P.T. Pham, P.C. Pham, G.M. Danovitch, D.J. Ross, H.A. Gritsch, and E.A. Kendrick Sirolimus-associated pulmonary toxicity Transplantation 77 2004 1215
47. R. Baluna, and E.S. Vitetta Vascular leak syndrome: a side effect of immunotherapy Immunopharmacology 37 1997 117
48. D.M. Klinman, I. Gursel, S. Klaschik, L. Dong, D. Currie, and H. Shirota Therapeutic potential of oligonucleotides expressing immunosuppressive TTAGGG motifs Ann N Y Acad Sci 1058 2005 87